Who Just Raised

Uvantis Therapeutics, Inc.

Columbia, MD ยท Biotechnology

Uvantis Therapeutics, Inc. is a biotechnology company based in Columbia, Maryland. In a Form D filed with the SEC on September 23, 2026, it reported raising $100,000 from 1 investor as part of an offering of up to $5,000,000. The first sale in the offering took place on September 10, 2026.

Amount raised
$100,000
Offering size
$5,000,000
Investors so far
1
First sale
September 10, 2026
Securities offered
Debt, Options or warrants
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Columbia, Maryland
Incorporated
Delaware, 2025
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $100,000 $5,000,000 1 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises in Maryland

Company Location Sector Raised Target Filed
ColoWatch, Inc. /MD/ Gaithersburg, MD Health Care $975K $3M
Templar Nova, Inc. Rockville, MD Health Care $7M $7M
Monocacy Therapeutics Inc. Monrovia, MD Health Care $25K $25K
Seraxis Holdings, Inc. Germantown, MD Health Care $10M $10M
Aromha, Inc. Potomac, MD Health Care $75K $75K
Functional Longevity Labs, Inc. Easton, MD Health Care $25K $1M